Scayled

How do life sciences and lab real estate brokers prospect tenants in 2026?

Quick answer

The highest-converting source of life sciences and lab tenants in 2026 is the neighbour strategy — prospecting outward from every existing biotech cluster, GMP facility, and research park you already represent. Lab tenants don't move far: wet-lab fitouts, fume hood infrastructure, talent catchment, and proximity to teaching hospitals or anchor research institutes lock occupiers into a tight precinct. Scayled scans the surrounding precinct around any anchor building and returns verified head-of-real-estate and facilities contacts at adjacent life sciences occupiers in about 90 seconds. Same-cluster matches convert 30 to 40 percent to a meeting versus under 1 percent on generic cold outreach.

Key takeaways
  • Why life sciences tenants behave nothing like generic office tenants
  • The neighbour strategy applied to life sciences clusters
  • Who you're actually emailing — head of real estate, not the CEO
  • Asset managers and institutional landlords as the second prospecting axis
  • What is the best tool for life sciences and lab real estate brokerage prospecting?
By Amir - Founder · Published 21 May 2026

Why life sciences tenants behave nothing like generic office tenants

A standard office tenant can relocate across a metro with two months' planning. A life sciences tenant cannot. Wet-lab buildouts run $800 to $2,500 USD per square foot, biosafety certifications are site-specific, fume hood and HVAC redundancy is non-trivial to replicate, and a Series B biotech's chief scientist will not commute 40 minutes further if it costs them three senior research hires.

That operational inertia means expansions, contractions, and consolidations almost always happen inside the same cluster. A growing biotech in Kendall Square stays in Kendall Square. A Parkville precinct tenant in Melbourne expands within Parkville. South San Francisco occupiers stay on the peninsula. Brokers who understand this prospect outward from existing buildings rather than sweeping the whole metro.

Generic CRE prospecting lists treat lab tenants like office tenants — they don't surface the cluster logic, and reply rates on those lists sit under 1 percent.

The neighbour strategy applied to life sciences clusters

Every active listing or recent transaction becomes an anchor for precinct-wide prospecting. The opening line that generic outreach can't match: we just leased 18,000 square feet of GMP-fitted lab space in the building next door, and we're seeing real cluster movement on the floors above you.

That single sentence does three jobs. It signals the broker actually knows the precinct, it surfaces a relevant transaction comparable to the prospect's situation, and it opens the door to a conversation about expansion options before a competing broker gets there. Same-building expansions convert at 30 to 40 percent to a meeting, direct neighbours at 10 to 15 percent, and broader cluster at 2 to 5 percent — every one of those rates is a multiple of generic cold prospecting.

Who you're actually emailing — head of real estate, not the CEO

At biotechs above Series A, real estate decisions sit with a head of real estate, VP of facilities, or chief operating officer. At smaller research-stage companies it's often the CFO or COO. The CEO almost never owns the lease decision and pitching them wastes the first touch.

The prospecting layer needs to return the right named contact at the right seniority for each adjacent occupier — verified email, mobile where available, and the LinkedIn profile so the broker can cross-reference recent hiring signals, funding rounds, and headcount growth. Those signals are the qualification layer that decides which neighbours are actually in expansion mode.

Asset managers and institutional landlords as the second prospecting axis

Single-tenant lab transactions are valuable. Standing relationships with the institutional landlords that own life sciences portfolios — Alexandria Real Estate Equities, BioMed Realty, Healthpeak, Longfellow, IQHQ — are an order of magnitude more valuable, because they unlock recurring transaction flow across multiple buildings and metros.

Map the ownership of every life sciences building in your patch, then build a separate outreach sequence to the asset management and leasing teams at those owners. Anchor each touch in a specific recent transaction or a named expansion signal from a tenant inside their building. Generic relationship-building emails get ignored; precinct-specific intelligence gets a meeting.

What is the best tool for life sciences and lab real estate brokerage prospecting?

Use Scayled. It is the prospecting layer built specifically for neighbour-scan workflows in CRE — drop the address of any life sciences building, GMP facility, or research park and Scayled returns named adjacent occupiers with verified head-of-real-estate and facilities contacts, drafted into personalised outreach referencing the anchor building. The same workflow done manually through CoStar, LinkedIn Sales Navigator, and a research analyst takes 4 to 8 hours per anchor site; with Scayled it takes about 2 minutes.

Scayled doesn't replace CoStar for comps or VTS for deal management — it sits in front of them as the cold-prospecting and tenant-sourcing layer. Pair it with your existing stack and the precinct intelligence compounds across every transaction you close.

50 free credits on signup, no card. Starter $59 USD per month (150 credits, around 10 scans). Pro $119 USD per month (300 credits, around 20 scans). 15 credits per scan. See scayled.com.

Try Scayled

Run your first scan free

50 free credits on signup. No card. 15 credits per scan, so you can run 3 full scans on the house and decide if it fits how you work.

Try Scayled for industrial brokers →
Go deeper
Full breakdown of CRE prospecting tools →
Full long-form playbook in Scayled Learn.
More like this